Stay updated on Duvelisib for COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Duvelisib for COVID-19 Clinical Trial page.

Latest updates to the Duvelisib for COVID-19 Clinical Trial page
- Check2 days agoChange DetectedThe page now includes new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and indicates recruitment has ended with 'No longer looking for participants'. It also updates the revision note to Revision: v3.6.0 and removes the older label 'Intervention / Treatment' and the previous revision note 'Revision: v3.5.5'.SummaryDifference0.4%

- Check9 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5. This is a minor update to the page documentation and does not alter study details.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange Detected- The page shows Revision: v3.5.4 replacing Revision: v3.5.3, indicating an updated document/version label. - This reflects a new revision cycle rather than substantive changes to the page content.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page footer now shows a newer ClinicalTrials.gov UI build/revision number (v3.5.3) instead of the previous one (v3.5.2), indicating an interface/version update rather than a change to the underlying study record.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check88 days agoChange DetectedThe site revision label was updated to v3.5.0, replacing the previous v3.4.3 revision.SummaryDifference0.1%

Stay in the know with updates to Duvelisib for COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Duvelisib for COVID-19 Clinical Trial page.